Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder
about
Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implicationsBarriers to hepatitis C antiviral therapy in HIV/HCV co-infected patients in the United States: a reviewSerum Serotonin Levels are Associated with Antiviral Therapy Outcomes in Patients with Chronic Hepatitis C.Psychiatric care of the patient with hepatitis C: a review of the literature.Depression and antiviral response to interferon-based therapy for hepatitis C virus infectionVulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study.Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidenceA longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C.Psychological, lifestyle and social predictors of hepatitis C treatment response: a systematic review.Recommendations for the management of hepatitis C virus infection among people who inject drugs.Changes in depressive symptoms and impact on treatment course among hepatitis C patients undergoing interferon-α and ribavirin therapy: a prospective evaluation.Multimethod assessment of baseline depression and relationship to hepatitis C treatment discontinuation.Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study.
P2860
Q26798477-33E04C45-A727-48D2-9B3C-61A107E962D0Q27010548-CF9C480D-D60C-4541-A26C-2E966C489448Q34395035-94129E47-EF3F-41C3-B8E1-677F797BA298Q34743058-58049ED2-83C0-4459-9A33-2ADC400B1AE4Q34779005-65896C3B-7C2E-498B-B18D-87B45A714AC5Q35535322-F7F089F1-EAD0-43A1-B9CC-DB37C2F646E9Q35540200-2714A751-C61B-431A-BDA7-193DA8F9D978Q35619107-983CA75C-2A9A-4E64-B632-08D2949C6FE5Q38098579-ADE823D6-0730-4C6A-8E25-500FA40ED891Q42280296-5D0B5919-BD94-4D20-B595-A43AED0B1C68Q43039554-8F5ADA9D-B56D-41CC-86AD-8FD623BFB9F1Q47558415-18B0342D-24FE-45DF-BA09-177528F405B3Q55050518-D31F775C-B61B-4C8D-8FF9-57965D01C593
P2860
Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Antiviral completion rates and ...... ting major depressive disorder
@ast
Antiviral completion rates and ...... ting major depressive disorder
@en
Antiviral completion rates and ...... ting major depressive disorder
@nl
type
label
Antiviral completion rates and ...... ting major depressive disorder
@ast
Antiviral completion rates and ...... ting major depressive disorder
@en
Antiviral completion rates and ...... ting major depressive disorder
@nl
prefLabel
Antiviral completion rates and ...... ting major depressive disorder
@ast
Antiviral completion rates and ...... ting major depressive disorder
@en
Antiviral completion rates and ...... ting major depressive disorder
@nl
P2093
P2860
P1433
P1476
Antiviral completion rates and ...... ting major depressive disorder
@en
P2093
Alex Linke
Annette Matthews
Benjamin J Morasco
Dannell Bjornson
David W Indest
Peter Hauser
Samantha Ruimy
P2860
P304
P356
10.1176/APPI.PSY.50.5.500
P577
2009-09-01T00:00:00Z